Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge gemäß § 130a Abs. 8c SGB V Rituximab, ATC L01FA01

AOK Bayern - Die Gesundheitskasse · Germany government procurement

Closed April 16, 2025. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

This is not an open procedure, but rather an open-house model! The form for the open procedure is only used because no form exists for the open-house model. Contracts concluded under the open-house model are not subject to procurement law due to the lack of a selection process. Using this form does not imply any obligation to comply with procurement regulations. The AOK Bayern - Die Gesundheitskasse, acting as a state association (§ 207 para. 4 SGB V), the BKK-Landesverband Bayern, the IKK classic acting as a state association (§ 207 para. 4a SGB V), consisting of the health insurance funds of the guild health insurance funds: IKK classic, IKK - Die Innovationskasse, IKK Südwest, BIG direkt gesund, IKK Brandenburg und Berlin, IKK gesund plus, the Social Insurance Institution for Agriculture, Forestry and Horticulture (SVLFG) as an agricultural health insurance fund, acting as a state association (§ 36 KVLG 1989), the KNAPPSCHAFT, the Techniker Krankenkasse (TK), the BARMER, the DAK - Gesundheit, the Kaufmännische Krankenkasse - KKH, the HEK - Hanseatische Krankenkasse, and the Handelskrankenkasse (hkk) intend to conclude non-exclusive discount agreements with all interested pharmaceutical companies regarding the active ingredient rituximab, ATC L01FA01, pursuant to § Pursuant to Section 130a Paragraph 8c of the German Social Code, Book V (SGB V), the following agreements are to be concluded for parenteral preparations made in pharmacies from finished medicinal products in oncology for immediate medical administration to patients in the region of Bavaria: AOK Bayern is authorized to conclude these discount agreements, to terminate them, and to perform other actions necessary within the framework of the open-house procedure. The contracting authorities offer all interested pharmaceutical companies that meet the eligibility requirements listed below the opportunity to conclude identical and non-negotiable discount agreements. The earliest possible start date for the...

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyAOK Bayern - Die Gesundheitskasse
CountryGermany
CategoryMedical Equipment
CPV33600000
PublishedApril 26, 2024
Procurement stageActive solicitation
ClosedApril 16, 2025
StatusClosed — no longer accepting responses
Official sourceView original notice
Last verifiedOctober 09, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Browse Similar Open Opportunities in Germany

Germany – Medical equipments, pharmaceuticals and personal care products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V i. V. m. § 31 Absatz 1 SGB V über Blutzuckerteststreifen, für die Zeit 01.01.26 - 31.12.27 (zzgl. V.-Option 1 x 24 Mon.)
Germany – Call centre – Vertrag über Callcenter-Leistungen zur Versichertenkommunikation Versorgungsverträge
Germany – Medical consumables – Open House Vertrag über die Versorgung mit patientenindividuell verordneten Verbandmitteln und sonstigen Produkten der Wundbehandlung § 31 Abs. 1a SGB V und Medizinprodukten mit Verbandmittelcharakter
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Erythropoietin, ATC B03AX01 (Kopie)
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Etonogestrel und Ethinylestradiol (Vaginalring mit Gestagenen und Estrogenen), ATC G02BB01
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Certolizumab pegol, ATC L04AB05
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Tocilizumab, ATC L04AC07
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Tiotropiumbromid, in der Darreichungsform Inhalationslösung (Respimat(R)), ATC R03BB04

See every Germany Medical Equipment opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Medical Equipment intelligence report in your inbox

A personalized report on Germany Medical Equipment opportunities, emailed in 5-10 minutes. One per month, no account needed.